Cell Therapeutics sales and marketing update

Cell Therapeutics launched Pixuvri pixantrone in the U.K. to treat multiply relapsed or refractory aggressive non-Hodgkin's B cell lymphoma. In February, the U.K.'s NICE issued final guidance recomme...